EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1991. Start Trial.
Date Value
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 -4.134
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 -1.264
June 30, 2024 -1.579
March 31, 2024 -25.16
December 31, 2023 -37.68
September 30, 2023 -5.795
June 30, 2023 -6.688
March 31, 2023 -107.29
December 31, 2022 -8.786
September 30, 2022 -1.134
June 30, 2022 -2.59
March 31, 2022 -10.96
December 31, 2021 -5.264
September 30, 2021 -4.463
June 30, 2021 -5.021
March 31, 2021 -17.26
December 31, 2020 -98.41
September 30, 2020 -4.202
June 30, 2020 -1.254
March 31, 2020 -2.36
Date Value
December 31, 2019 -120.00
September 30, 2019 -2.32
June 30, 2019 -2.66
March 31, 2019 -5.86
December 31, 2018 -109.00
September 30, 2018 -1.48
June 30, 2018 -1.56
March 31, 2018 920.00
December 31, 2017 -2.66
September 30, 2017 -2.58
June 30, 2017 -2.54
March 31, 2017 -67.36
December 31, 2016 -44.36
September 30, 2016 260.00
June 30, 2016 -20.00
March 31, 2016 -9.04
December 31, 2015 -20.00
September 30, 2015 -8.28
June 30, 2015 -7.20
March 31, 2015 -9.36
December 31, 2014 -6.20
September 30, 2014 -8.02
June 30, 2014 -8.70
March 31, 2014 -20.00
December 31, 2013 -4.52

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Compugen Ltd. -0.074

EPS Diluted (Quarterly) Related Metrics